Ingevity Corporation

As of June 30, 2026, Ingevity Corporation carries a market capitalization of 2.27B, placing it among publicly traded companies globally. Its enterprise value stands at 3.26B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Ingevity Corporation's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Ingevity Corporation has 34.48M shares outstanding.

As of June 30, 2026, Ingevity Corporation trades at a trailing price-to-earnings ratio of 49.38. The price-to-sales ratio is 2.30, and the price-to-book ratio stands at 55.23.

As of June 30, 2026, Ingevity Corporation trades at an EV/EBITDA multiple of 16.40 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.41 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Ingevity Corporation trades at an EV/FCF ratio of 14.52, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 3.26B versus a market cap of 2.27B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Ingevity Corporation maintains a current ratio of 1.61, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2,636.03, indicating elevated leverage, while an interest coverage ratio of 3.31 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Ingevity Corporation posted a return on equity (ROE) of 64.44, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.07 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.16, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.19, useful for judging operating efficiency across full business cycles. The company generates approximately 665,974.16 in revenue per employee across its workforce of 1,525.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.65 indicates how many times Ingevity Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Ingevity Corporation recorded 10.94M in income tax expense. That works out to an effective tax rate of 33.16, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 33.00M, leaving 47.27M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Ingevity Corporation's stock has gained approximately 29.30% over the past 52 weeks. The 50-day moving average sits at 61.58, while the 200-day moving average is 61.37.

Over the twelve months ended June 30, 2026, Ingevity Corporation generated 1.02B in revenue and converted that into 47.27M in net income, yielding earnings per share of 0.61. EBITDA reached 199.04M, while operating income came in at 249.02M.

As of June 30, 2026, Ingevity Corporation holds 85.25M in cash and equivalents against 1.08B in total debt, resulting in a net debt position of 965.28M. Total book value stands at 41.05M, with working capital of 180.49M providing operational flexibility.

Ingevity Corporation produced 184.69M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Ingevity Corporation posted a gross margin of 41.12, reflecting its pricing power and cost economics. The operating margin of 24.52 and net profit margin of 4.65 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 7.80, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 10.72, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ingevity Corporation shareholders.

As of June 30, 2026, Ingevity Corporation has an Altman Z-Score of 3.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.